A Systematic Review of Clinical Trials on the Efficacy and Safety of CRLX101 Cyclodextrin-Based Nanomedicine for Cancer Treatment

CRLX101 is a cyclodextrin-based nanopharmaceutical designed to improve the delivery and efficacy of the anti-cancer drug camptothecin. Cyclodextrins have unique properties that can enhance drug solubility, stability, and bioavailability, making them an attractive option for drug delivery. The use of...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Serrano-Martínez (Author), Desirée Victoria-Montesinos (Author), Ana María García-Muñoz (Author), Pilar Hernández-Sánchez (Author), Carmen Lucas-Abellán (Author), Rebeca González-Louzao (Author)
Format: Book
Published: MDPI AG, 2023-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available